Quest Partners LLC boosted its position in Maximus, Inc. (NYSE:MMS – Free Report) by 95.2% during the third quarter, Holdings Channel reports. The institutional investor owned 37,488 shares of the health services provider’s stock after purchasing an additional 18,286 shares during the quarter. Maximus comprises approximately 0.3% of Quest Partners LLC’s portfolio, making the stock its 27th largest holding. Quest Partners LLC’s holdings in Maximus were worth $3,492,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of MMS. Assenagon Asset Management S.A. grew its stake in shares of Maximus by 277.0% in the third quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider’s stock valued at $81,878,000 after buying an additional 645,760 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its stake in shares of Maximus by 942.9% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock worth $27,707,000 after purchasing an additional 292,300 shares during the period. Millennium Management LLC lifted its holdings in shares of Maximus by 150.4% during the second quarter. Millennium Management LLC now owns 406,075 shares of the health services provider’s stock worth $34,801,000 after buying an additional 243,890 shares in the last quarter. Vanguard Group Inc. raised its stake in Maximus by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 6,208,839 shares of the health services provider’s stock worth $520,922,000 after purchasing an additional 145,983 shares in the last quarter. Finally, Algert Global LLC bought a new stake in shares of Maximus in the second quarter valued at approximately $12,424,000. Institutional investors own 97.21% of the company’s stock.
Maximus Trading Down 2.3 %
MMS opened at $79.18 on Monday. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $4.77 billion, a price-to-earnings ratio of 16.60 and a beta of 0.77. The company has a 50-day simple moving average of $89.02 and a 200 day simple moving average of $88.22. Maximus, Inc. has a twelve month low of $76.42 and a twelve month high of $93.97.
Maximus Announces Dividend
Insider Activity at Maximus
In other Maximus news, insider Michelle F. Link sold 1,363 shares of the company’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total value of $126,159.28. Following the completion of the transaction, the insider now owns 6,567 shares of the company’s stock, valued at $607,841.52. This represents a 17.19 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.40% of the stock is owned by insiders.
About Maximus
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Read More
- Five stocks we like better than Maximus
- What to Know About Investing in Penny Stocks
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- The Significance of Brokerage Rankings in Stock Selection
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.